/Investor DB

SOSV — 2024 Investments

22 investments dated 2024 · listed companies and verified rows first · show all

Afyniaafynia.comin𝕏Jul 2024 · $2M✓ verified

Afynia develops diagnostic tools focused on women's health, with an emphasis on endometriosis detection through diagnostic biomarkers.

BiotechDigital HealthFemTechMedical Devices

Dr. Lauren Foster(Co-Founder, Chief Executive Officer)Dr. Jocelyn Wessels(Co-Founder, Chief Scientific Officer)Warren (Lauren) Foster, Ph.D., FCAHS(Founder)inDr. Jake Prigoff(Chief Medical Officer)Darren Farry(Chief Financial Officer)

Co-investorsGaingelsImpact America Fund

Swap Roboticsswaprobotics.cominAug 2024✓ verified

Swap Robotics builds heavy-duty robots for utility-scale solar sites, handling vegetation cutting, solar module installation, and materials staging such as i-beams, torque tubes, and pallets.

AI & Machine LearningCleantechEnergyHardwareRoboticsKitchener, CA

Timothy Lichti(Executive Officer, Director, Promoter)Mohamed Hassan(Founder)inMohamed Hassan .(Founder)inSpencer Kschesinski(Executive Officer)inAdonis Mansour(Executive Officer)inMohamed Mostafa(Executive Officer)

Co-investorsInnovative Solutions CanadaMaple Leaf Angels

Aequoraequorinc.cominSeed · Jan 2024 · $200K

Aequor develops EPA-approved green chemical compounds that replace toxic biocides for controlling bacteria, fungi, and marine fouling in industrial and consumer applications.

AgTechBiotechCircular EconomyCleantechClimate TechNew MaterialsOceanside, US

Cynthia Burzell(Co-founder)Marilyn Bruno(CEO)inKeith Di Fiore(Chief Strategy Officer)in

Algomaalgoma.coin𝕏Nov 2024

Algoma provides a software platform for real estate developers that generates site feasibility analysis for US parcels, including zoning research, GIS data layers, generative site layouts, renderings, and market intelligence.

AI & Machine LearningConstruction TechPropTechNewark, US

Josef Bromovsky(CEO & Co-Founder)Seyfihan Usarer(COO & Co-Founder)inKyle MertensMeyer(CPO & Co-Founder)inJoe Bromovsky(Founder)inWassim Alagha(Head of Computation)inWilliam MacIntyre(Head of Engineering)in

Co-investorsDOMiNO VenturesIron PrairieModerne VenturesZacua Ventures

Alixiaalixia.cominSeed · Jul 2024

Alixia develops therapeutics targeting tumor ecosystems to address cancer drug resistance and age-related diseases.

BiotechDeep TechHealthtechMedical DevicesSan Francisco, US

Olof Mollstedt(Founder)inHelen Chen(Founder)in

BoardSungwon Lim(Director)

Co-investorsEight CapitalGaingelsStartXY CombinatorZAKA VCAJG+1 more

Allozymesallozymes.cominMay 2024 · $15M

Allozymes develops custom enzymes using high-throughput experimentation combined with AI-guided design for enzyme engineering and biocatalysis.

AI & Machine LearningBiotechDeep TechNew MaterialsSingapore, SG

Peyman Salehian(Chief Executive Officer, Co-Founder)inAkbar Vahidi(Chief Technical Officer, Co-Founder)in

Co-investorsEntrepreneur FirstHAXSeventure PartnersTranspose Platform ManagementXora Innovation Pte Ltd

Capra Biosciencescaprabiosciences.cominOct 2024

Alexandria, US

Andrew Magyar(Executive Officer, Director)inElizabeth Onderko(Executive Officer, Director, Promoter)in

BoardPae Wu(Director)inDanielle Joseph(Director)inDouglas Cameron(Director)

Co-investorsAlumni VenturesBlue Ivy VenturesFirst Bight VenturesGS FuturesThe E14 FundClosed Loop Partners+1 more

Chronus Healthchronushealth.comJan 2024

HealthtechMountain View, US

Ashish Jagtiani(Executive Officer, Director)Anand Parikh(Executive Officer, Director)

Co-investorsMAGIC FundMonta Vista Capital

Everbloomeverbloom.app𝕏Apr 2024 · $250K

Everbloom provides upfront growth capital to online content creators (e.g.

Creator EconomyFintechMedia & Entertainment

Co-investorsBollinger Investment GroupHoxton VenturesTuesday Capital

Hexem Biohexemb.ioinSeed · Sep 2024

Developing regenerative therapies to improve bone marrow transplantation outcomes and extend healthspan.

Mo Ebrahimkhani(CSO)inJoshua Hislop(CTO)Samira Kiani(COO)

Co-investorsAlumni VenturesDraper AssociatesE2MC VenturesEmerald Development ManagersGaingelsSeraphim Space+3 more

Hyperlumehyperlume.comin𝕏Nov 2024

Hyperlume develops copper interconnect and Active Electrical Cable (AEC) connectivity solutions supporting data rates from 100G up to 1.6T for data centers and AI deployments.

Deep TechHardwareSemiconductorsOttawa

Mohsen Asad(Founder)inCharles Lesperance(Director)Hossein Fariborzi(President, Treasurer and Chief Technology Officer.)

Co-investorsArcTern VenturesLG Technology VenturesUCeed FundsCelesta CapitalIntel Capital

Level Zero Healthlevelzerohealth.cominDec 2024

Level Zero Health develops electrochemical and microfluidic biosensor platforms for point-of-care and continuous diagnostic devices.

BiotechHealthtechMedical DevicesDover, US

Ula Rustamova(CEO)inIrene Jia(CTO)inUlviyya Rustamova(Executive Officer, Director)Yiran Jia(Director)

BoardPhilip Kneis(Director)in

Co-investorsAnorak VenturesBlack Jays VenturesEntrepreneur FirstKfundSamos InvestmentsTranspose Platform Management+2 more

Nukokonukoko.co.ukinMar 2024

Nukoko makes cocoa-free chocolate alternatives using European-grown fava beans, positioned as a lower-carbon, more sustainable option.

Circular EconomyClimate TechFoodTech

Ross Newton(Founder)in

Co-investorsKickstart InnovationOyster Bay Venture CapitalDoehler Ventures

OneSkinoneskin.coNov 2024 · $7M

OneSkin develops skincare products based on its OS-01 Peptide, an ingredient the company says targets cellular senescence to address signs of skin aging.

BiotechConsumerDirect to ConsumerLongevityWellness & FitnessSan Francisco, US

Carolina Reis de Oliveira(Executive Officer, Director)inAlessandra Zonari(Co-founder & Chief Scientific Officer)inCarolina Reis Oliveira(Co-founder & CEO)inAlessandra Zonari Scheel(Founder)inMariana Boroni, PhD(Co-founder)Juliana Carvalho, PhD(Co-founder)

Co-investorsAble PartnersMetaplanetPHD VenturesPLUS CapitalSelva VenturesUnilever Ventures+1 more

Prolific Machinesprolific-machines.cominJun 2024 · $55M

Prolific Machines licenses an optogenetics platform that adds light-based control to cell line development and GMP biomanufacturing, letting biopharma teams retrofit existing bioreactors and hosts to raise titers and manufacture complex molecule formats.

Advanced ManufacturingAI & Machine LearningBiotechDeep TechEmeryville, US

Maximilian HörnerinMax Huisman(Founder)inDeniz Kent(Founder)inDeniz Kent, Ph.D.(Founder)inDeclan Jones(Founder)inShahram Misaghiin

Co-investorsBaruch Future VenturesBreakthrough Energy VenturesDarco CapitalIn-Q-TelMayfield FundSolari Capital+3 more

Samphire Neurosciencesamphireneuro.cominFeb 2024 · $2.3M

Samphire Neuro develops brain-based neurotechnology medical devices to treat chronic pain and mood conditions in women, targeting PMDD, dysmenorrhea, perimenopause, chronic migraines, and endometriosis.

Digital HealthFemTechMedical Devices

Emilė Radytė(CEO (Founder))inAlex Cook(COO (Founder))inErvinas Bern(CTO)inKendell Cannon(Chief Medical Officer)

Co-investorsAfterWork VenturesAlberts Impact VenturesAngel AcademeCVX VenturesFirstpickFortify Ventures+4 more

Terran Roboticsterranrobotics.aiin𝕏Oct 2024

Terran Robotics builds AI-driven terraforming robots that construct residential and commercial buildings from earthen materials at a fraction of conventional construction costs.

Construction TechHardwarePropTechRoboticsBloomington, US

Zach Dwiel(Co-Founder, CEO & Chief Engineer)Danny Weddle(Co-Founder & Chief Design Officer)

Co-investorsDeep FutureRolling Fun GPThird DerivativeUnruly Capital

Voyage Foodsvoyagefoods.comMay 2024

Voyage Foods develops B2B ingredients that create sustainable, stable alternatives to traditional commodity sources for popular foods and beverages, addressing volatility in global ingredient markets and climate risks.

AgTechClimate TechFoodTechOakland, US

Adam Maxwell(Executive Officer, Director)

BoardStephen George(Director)Alec Lee(Director)James Stewart(Director)inGary Wu(Director)

Co-investors885 CapitalBloom8Cerity Partners VenturesCollaborative FundHorizons VenturesLevel One Fund+4 more

ZymoChemzymochem.comin𝕏Jan 2024 · $21M

ZymoChem develops bio-based materials using proprietary Carbon Conserving (C2) microbes that convert renewable feedstocks into high-value materials with increased yields.

BiotechCircular EconomyClimate TechNew MaterialsSan Leandro, US

Harshal Chokhawala(Chief Executive Officer & Co-Founder)inLindy Fishburne(Director)Phil Grayeski(Director)Taehong Huh(Director)Timothy Dummer(Executive Officer, Director)Jon Kuchenreuther(Co-Founder)

Co-investorsAccelr8Breakout LabsBreakout VenturesCavallo VenturesDudley FundFreshTracks Capital+8 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Tasca TherapeuticsBacteryMixRift

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.